Company Profile

Company Description

Cingulate Inc. is a biopharmaceutical firm specializing in the development of innovative treatments for central nervous system (CNS) disorders. Leveraging its proprietary precision-timed release (PTR) drug delivery platform, the company focuses on improving therapeutic outcomes for conditions like ADHD and anxiety. Its approach aims to enhance efficacy, reduce side effects, and optimize patient adherence through advanced formulation technologies. By targeting unmet medical needs, the company strives to bring transformative solutions to the healthcare market, supported by rigorous clinical research and development. Its pipeline reflects a commitment to addressing complex neurological challenges with cutting-edge science.